Consider what happens when this foundation is inadequate. An investigator administers a compound that has never been tested in the relevant animal models. A sponsor designs a trial based on outdated assumptions about disease progression. A protocol proceeds unchanged despite emerging evidence that challenges its premises. In each case, participants are exposed to risks that current scientific knowledge might have avoided.

Principle 4 of ICH E6(R3) addresses this directly. It requires that clinical trials be scientifically sound for their intended purpose and based on adequate and current scientific knowledge. This is not merely an aspiration; it is a regulatory obligation that shapes how trials are designed, conducted, and modified over time.

The scientific foundation of a clinical trial does two things simultaneously. First, it protects participants by ensuring that risks are justified by what is known. Second, it protects the integrity of the research enterprise by ensuring that trials can actually answer the questions they pose. A poorly designed trial wastes resources, exposes participants to risk for no benefit, and fails to advance medical knowledge. Scientific soundness prevents these outcomes.

Consider what happens when this foundation is inadequate. An investigator administers a compound that has never been tested in the relevant animal models. A sponsor designs a trial based on outdated assumptions about disease progression. A protocol proceeds unchanged despite emerging evidence that challenges its premises. In each case, participants are exposed to risks that current scientific knowledge might have avoided.

Principle 4 of ICH E6(R3) addresses this directly. It requires that clinical trials be scientifically sound for their intended purpose and based on adequate and current scientific knowledge. This is not merely an aspiration; it is a regulatory obligation that shapes how trials are designed, conducted, and modified over time.

The scientific foundation of a clinical trial does two things simultaneously. First, it protects participants by ensuring that risks are justified by what is known. Second, it protects the integrity of the research enterprise by ensuring that trials can actually answer the questions they pose. A poorly designed trial wastes resources, exposes participants to risk for no benefit, and fails to advance medical knowledge. Scientific soundness prevents these outcomes.